{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JWr7ZgKDA","lastupdate":"2020-11-12T00:00:00.000Z","update_date":"2020-11-12T00:00:00.000Z","lastModified":"Nov 12, 2020","active":1,"confidence_score":52,"confidence_score_reason":"funding stage, homepage, not claimed, portfolio, total companies graduated, number of companies in a class, address","urlname":"adama-health-tech-accelerator","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"description_edited":0,"tag_line_edited":0,"phone":"","biverification":"Jenny Sotnik-Talisman","recentupdates":[{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 08:09:18.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:00:39.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:51:03.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:48:15.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:48:15.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:48:15.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:55:17.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:38:39.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:38:39.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:03:56.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:03:56.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:20:43.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:34:10.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:34:10.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:29:46.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:29:46.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:04:43.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:09:03.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:09:03.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:23:25.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:23:25.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:56:41.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:35:15.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:58:13.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 08:08:55.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:58:13.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:58:13.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:40:04.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:40:04.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:58:13.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:09:25.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:56:42.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:56:42.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:06:28.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:24:26.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:39:14.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:39:14.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:04:11.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:32:15.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:32:15.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:49:41.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:07:44.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:18:51.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:57:46.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:57:37.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:18:25.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:58:26.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 08:09:29.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:56:12.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2020-10-06 06:50:25.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2020-10-06 06:50:25.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:56:12.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:56:12.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 07:56:41.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 08:02:18.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"yanina.wain@gmail.com","source":"Manual","datetime":"2020-11-02 19:05:14.000000","last_name":"Wainscheinker","first_name":"Yanina"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:09:19.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:09:19.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:52:11.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:52:11.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 08:00:35.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:22:08.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:41:58.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:41:58.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:55:24.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:28:58.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 08:03:31.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 08:01:48.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:18:18.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 08:05:13.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:36:13.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:50:36.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 10:42:23.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-10-05 11:08:32.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 10:31:30.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:06:53.000000","last_name":"Gorokhovsky","first_name":"Hilla"},{"email":"hilla.gorokhovsky@sncentral.org","source":"Manual","datetime":"2020-11-12 11:06:53.000000","last_name":"Gorokhovsky","first_name":"Hilla"}],"logokey":"$VC8mZCh5vCOTVHwGZDwKhguANfujXOssaFjEzZSssuUNDOhkyA7z9d","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-10-06T00:00:00.000Z","crunchbaseid":"","lastupdator":"Hilla Gorokhovsky","lastupdator_email":"hilla.gorokhovsky@sncentral.org","creator":"Hilla Gorokhovsky","creator_email":"hilla.gorokhovsky@sncentral.org","createdate":"2020-10-05T00:00:00.000Z","hide_reason":null,"hide_reason_data":null,"name":"ADAMA Health-Tech Accelerator","registrar":"","type":"Corporate Accelerator","subtype":"","about":"The ADAMA Health-Tech Accelerator at Samson Assuta Ashdod Hospital, that was created in collaboration with eHealth Ventures incubator, is a 10 weeks intensive program designed to support hospital staff in their efforts to develop, test and implement new approaches to improve health care quality, efficiency and delivery. Working closely with mentors from high tech companies, tech incubators and academic institutions, this program offers Assuta Ashdods entrepreneurs the knowledge, tools and guidance to promote their innovation and advance their idea from inception to bringing successful innovations to scale. \r\nThe ADAMA Health-Tech Accelerator is also opened to medical projects from outside the hospital to participate, establishing the program as southern Israels medical entrepreneurship hub. \r\nThe Department of Innovation and Medical Entrepreneurship at the Assuta Ashdod Hospital works to promote changes in the health system in general and in the hospital in particular, in various issues such as internal and external organizational processes, technological development and research. The department promotes networking based on the diversity of professionals from different fields and working in integrated multidisciplinary teams to promote and develop ideas. \r\n","founded_month":4,"founded_year":2019,"inisraelsince":"","inisraelsincemonth":"","formernames":[],"duration":"3m","batchsize":"","batchesperyear":"1","graduates":0,"maxinvestmentpercompany":null,"verticalaccelerator":1,"academia_supported":0,"academia":null,"takesequity":0,"participationfee":0,"feeamount":null,"officespaces":"0","eventsperyear":"","numberofmembers":"","membershiptype":"","investment_amount":null,"country":"Israel","representing_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLXWvZoLDA","representing":"eHealth Ventures","alternativenames":["ADAMA accelerator","Assuta Ashdod accelerator","Adama-Assuta program","eHealth Ventures Physician-Entrepreneurs Acceleration Program","ADAMA Health-Tech accelerator","Assuta Ashdod- ADAMA program"],"employees_overall":null,"isisraeli":1,"oneliner":"","website":"","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"team":[{"name":"Gil  Levy","email":"gille@assuta.co.il","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4J2qz8IIDA","bounced":false,"claimed":0,"founder":0,"urlname":"gil-levy-4","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgrfWAmgkM","position":"Head of innovation unit Assuta","last_name":"Levy","claimtoken":"6a83e08cde9aeff957b2d937b3be07839421437c0f9ab04769e8ee8eab28cf57","first_name":"Gil ","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-11-12 11:06:57.000000","initials":"GL","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Maya Alcalay","email":"mayaal@assuta.co.il","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4K21zdIKDA","bounced":false,"claimed":0,"founder":0,"urlname":"maya-alcalay","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgjcu2rAoM","position":"Innovation unit Assuta","last_name":"Alcalay","claimtoken":"8251d32223fb95dcc5c611eba1f64277f91b3b25dea808a3dfe4ba7b6751424b","first_name":"Maya","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/maya-alcalay-23b57436/","unsubscribed":true,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"MA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"alumni":[],"covers":null,"subcommunities":null,"utilities":[],"supporters":null,"databases":[],"sharedspaces":[],"hide_reasons":[{"id":"36yxJmd8VBSFnHL7vnFmGT4a3zqmnRimw0oZHjt7JO3TlHmxE4mfGk","reason":"Scouting program"},{"id":"3P3LBMOo0qLbkFJSYom5ZHiJ3EkB5s7Sh8LLZzEu4qJCFuTIYnRFJj","reason":"Owner asked to hide in the meantime"},{"id":"9YRjRjneNFwSiPcabVNwQPQVWSlY1UA8fLewNgoazJXj9poz4Qxj8B","reason":"Non technology program"},{"id":"EkCaBLpauStnsNjOy3a3o5fp5ByFUQXES31HWEiufpvGoj6jYC8yuo","reason":"Pending approval"},{"id":"eL072mR3fOyGOAuEjexFBf87nVeMgRWqbi0IkcKywBqgIRTYqG0abA","reason":"Pending approval - External entity"},{"id":"FL6RZUmPTjcsACgSZJaOfNmAufKP3Tmm9GLSnhkubh5tdkP6x2VS63","reason":"The hub is not israeli"},{"id":"hjkHnQS0UkLkFNQrOXy1IBzD65FOlOgBsBkEYlVfUouUVu8bvKBnub","reason":"Only foreign companies in program"},{"id":"ic09OdY9s60fj0Q3YQchA9PvsjnAtReroBygRRmOdxLmwOneKPmzFC","reason":"Part of existing program in Finder"},{"id":"uMEVRdB2yMstoSlojEH9yjleK8xuogo1ohkJ2UVVdSbrGT6uhGOOTO","reason":"Owner asked to delete"},{"id":"VzLfzYUTUEnOYWz7ND4xoDyFWgF2zkzEhbZYvGnXzYLLa3wb66q6mX","reason":"This program is a service provider"}],"mediagallery":[],"address":{"israeli":[{"id":"f952e4c4-0aa1-46dd-86b8-a3cdcd4c6fd4","city":"Ashdod","type":null,"address":"Ashdod, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"news":[{"id":"vdxhbiVGHnzQ8Gnm5iUz9I17wFrmfEBVcl2qRzsU0E22BOJXml1FQP","date":"Jul 14, 2025","link":"https://www.prnewswire.com/il/news-releases/adama-provides-financial-performance-estimation-for-the-first-half-of-2025-302504236.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"financial performance","round":null,"company":"ADAMA Ltd.","layoffs":null,"summary":"ADAMA Ltd. has provided an estimate of its financial performance for the first half of 2025, showing a positive impact from its Fight Forward strategic transformation plan. The company expects flat sales compared to the first half of 2024, with volume growth offsetting lower prices. ADAMA anticipates an increase in adjusted EBITDA and net profit, with an expected adjusted net profit between USD 47 million to 54 million, compared to a loss in the previous year. The improvement is attributed to higher gross profit margins and lower costs. The company also expects a narrowed reported net loss. These results are preliminary and unaudited, with final financial statements expected on August 26, 2025.","partners":[],"customers":[],"eventType":null,"investors":[],"confidence":9,"key_topics":["financial performance","strategic transformation","EBITDA growth","net profit","cost management"],"date_of_event":"August 26, 2025","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"M3AUZX8TCQWOxbW19OGC3e22cVpvKPuKq88cqWNTStQYBz91Jc46d1","news_summary":"/PRNewswire/ -- ADAMA Ltd. (the \"Company\") (SZSE: 000553), today provided an estimate regarding its financial performance for the first half of 2025. The...","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"1DNstPd5furONDTEck9O8fkcylcg37CcnkFXLfiOcmDEJdiRchxR5B","date":"Mar 13, 2025","link":"https://www.prnewswire.com/il/news-releases/adama-reports-fourth-quarter-and-full-year-2024-results-302401101.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"transformation","round":null,"company":"ADAMA Ltd.","layoffs":null,"summary":"ADAMA Ltd. reported its financial results for Q4 and the full year of 2024, highlighting the initial success of its Fight Forward strategic transformation plan. Despite a 2% decrease in Q4 sales, the company saw a 14% increase in adjusted gross profit and a 45% rise in adjusted EBITDA. The plan focuses on optimizing financial management, streamlining operations, and focusing on value innovation. ADAMA launched several new products and continued to enhance its sustainability efforts. The company improved its cash flow and reduced its net loss, indicating positive momentum for future growth.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["financial results","strategic plan","product launches","sustainability","market performance"],"date_of_event":"2024","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"yHNB5eTP11fs9IrQ0Z6Abmj59JV4g9FveApJcguujrgs6J6F2LooyF","news_summary":"/PRNewswire/ -- ADAMA Ltd. (the \"Company\") (SZSE 000553), today reported its financial results for the fourth quarter and full year ended December 31, 2024....","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"7e295393-1880-411a-a3b0-6fd2403a0da1","date":"Oct 27, 2020","link":"https://www.jpost.com/health-science/tech-accelerator-showcasing-creative-medical-solutions-wraps-up-in-ashdod-647102","source":"www.jpost.com","visible":1,"analysis":{"tags":"medical entrepreneurship","company":"Adama","layoffs":null,"summary":"The Adama Accelerator for Medical Entrepreneurship, organized by Adama, has concluded its program showcasing twelve projects aimed at finding innovative solutions to medical challenges. The projects include early detection and diagnosis of viruses like COVID-19, AI-based detection of fetal distress, and a smartphone app for muscle stimulation. The accelerator provided mentorship and guidance to the participants, helping them develop business models, marketing strategies, and pitches to potential investors. The final event was streamed live to hospital managers, employees, and potential investors. Adama, a leading generic crop protection company, supports the accelerator as part of its commitment to technology, entrepreneurship, and innovation. The company believes that the program will contribute to the development of new projects that benefit the medical world and hospital patients.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Adama Accelerator","Medical Entrepreneurship","Innovative Technological Advances","Assuta Ashdod University Hospital","COVID-19 Detection"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Pf6vfk9IotsrL5Ww8WBV95LCkl5D2614RGzkk0ayTbE3PcugK8hwR0","news_summary":"https://www.jpost.com/health-science/tech-accelerator-showcasing-creative-medical-solutions-wraps-up-in-ashdod-647102","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"timeline":[],"techcommunityinvolvement":null,"affiliatedOrganizations":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLXWvZoLDA","name":"eHealth Ventures","type":"Investor","hidden":false,"fullurl":"/investor_page/ehealth-ventures","logokey":"$hTOVCoOHKUxhQeTyAFXk35LWjoJrs02OWLlvHOJKuQLVZbHgru8ZWT.PNG","logourl":"https://storage.googleapis.com/clean-finder-353810/$hTOVCoOHKUxhQeTyAFXk35LWjoJrs02OWLlvHOJKuQLVZbHgru8ZWT.PNG","onClick":"","visibilityClassName":"","visibilityTooltip":""}],"tags":["healthcare","medical-devices","digital-healthcare"],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"4/2019","contributors":[],"employeesworldwide":"","fundingtype":"","parsedName":"ADAMA Health-Tech Accelerator","logourl":"https://storage.googleapis.com/clean-finder-353810/$VC8mZCh5vCOTVHwGZDwKhguANfujXOssaFjEzZSssuUNDOhkyA7z9d","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$VC8mZCh5vCOTVHwGZDwKhguANfujXOssaFjEzZSssuUNDOhkyA7z9d","teamMembersNumber":2,"durationNumber":3,"nationality":"Israeli","communityinvolvement":[],"officespacesstr":"NO","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}